Real-world effectiveness of biologic therapies among patients with moderate-to-severe ulcerative colitis in the United States

被引：0
|
作者：
Erin, Comerford [1 ]
Marco, DiBonaventura [2 ]
Timothy, Smith [2 ]
Anthony, Louder [1 ]
David, Gruben [3 ]
Leonardo, Salese [4 ]
Daniel, Quirk [4 ]
机构：
[1] Aetion Inc, New York, NY USA
[2] Pfizer Inc, New York, NY USA
[3] Pfizer Inc, Groton, CT 06340 USA
[4] Pfizer Inc, Collegeville, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P025
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [1] Real World Effectiveness of Advanced Therapies Among Patients With Moderate-to-Severe Ulcerative Colitis in the United States
    Smith, Timothy W.
    DiBonaventura, Marco
    Gruben, David
    Bargo, Danielle
    Salese, Leonardo
    Quirk, Daniel
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S353 - S353
  • [2] Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States
    Long, Millie D.
    Smith, Timothy W.
    Dibonaventura, Marco
    Gruben, David
    Bargo, Danielle
    Salese, Leonardo
    Quirk, Daniel
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 (06) : 941 - 948
  • [3] Treatment Patterns Among Patients With Moderate-to-Severe Ulcerative Colitis in the United States
    DiBonaventura, Marco
    Bargo, Danielle
    Lucas, James
    Bluff, Daniel
    Hoskin, Ben
    Salese, Leonardo
    Cappelleri, Joseph C.
    Quirk, Daniel
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S353 - S353
  • [4] Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe
    Armuzzi, Alessandro
    DiBonaventura, Marco daCosta
    Tarallo, Miriam
    Lucas, James
    Bluff, Daniel
    Hoskin, Benjamin
    Bargo, Danielle
    Cappelleri, Joseph C.
    Quirk, Daniel
    Salese, Leonardo
    [J]. PLOS ONE, 2020, 15 (01):
  • [5] Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review
    Irving, Peter M.
    Hur, Peter
    Gautam, Raju
    Guo, Xiang
    Vermeire, Severine
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (09): : 1026 - 1040
  • [6] Real-World Patterns and Economic Burden Associated With Treatment Failure With Advanced Therapies in Patients With Moderate-to-Severe Ulcerative Colitis
    Lee, Scott D.
    Betts, Keith A.
    Du, Ella Xiaoyan
    Nie, Xiaoyu
    Gupte-Singh, Komal
    Ritter, Timothy
    [J]. CROHNS & COLITIS 360, 2024, 6 (02)
  • [7] REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS IN THE UNITED STATES OF AMERICA
    Burbage, Sabree
    Harvey, Niamh
    Godwin, Bridget
    Meadows, Rachael
    Knight, Hannah
    Zhao, Ruizhi
    Kachroo, Sumesh
    [J]. INFLAMMATORY BOWEL DISEASES, 2024, 30 : S86 - S87
  • [8] Efficacy of tofacitinib for the treatment of moderate-to-severe ulcerative colitis: real-world data
    Xiao, Y.
    Lakatos, P. L.
    Bourdages, R.
    Bitton, A.
    Afif, W.
    Kohen, R.
    Berberi, M.
    Bessissow, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S445 - S445
  • [9] Efficacy and safety of tofacitinib in patients with moderate-to-severe ulcerative colitis: A real-world retrospective study
    Yoshimura, N.
    Okano, Soh
    Sako, Minako
    Takazoe, Masakazu
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S545 - S545
  • [10] REAL-WORLD DOSE ESCALATION IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW OF LITERATURE
    Singh, Harpreet
    Pandey, Anuja
    Wilson, Liam
    Tencer, Tom
    Kumar, Jinender
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S26 - S26
12345